Key result
Supplementation of ECMS in a commercial FMD vaccine significantly enhanced FMDV-specific indirect hemagglutination assay titers and VP1-specific IgG and subclasses in pigs.
Why the study?
Does ECMS supplementation in FMD vaccines improve serological immune responses in guinea pigs and pigs?
Does ECMS supplementation in FMD vaccines improve serological immune responses in guinea pigs and pigs?
ECMS acts as an effective adjuvant to enhance the serological immune response to the FMD vaccine in animal models.
Answers are grounded in this paper and cite their sources.
ECMS boosts FMD vaccine immunogenicity in pigs; hypothesis-generating for adjuvant efficacy, with no support for clinical or field use yet.
Foot-and-mouth disease (FMD) is a highly contagious disease affecting cloven-hoofed animals. Vaccination against FMD is a routine practice in many countries where the disease is endemic. This study was designed first to investigate the extract of the seeds of Momordica cochinchinensis (Lour.) Spreng. (ECMS) for its adjuvant effect on vaccination of inactivated FMDV antigens in a guinea pig model and then to evaluate the supplement of ECMS in oil-emulsified FMD vaccines for its immunopotentiation in pigs. The results indicated that ECMS and oil emulsion act synergistically as adjuvants to promote the production of FMDV- and VP1-specific immunoglobulin G (IgG) and subclasses in guinea pigs. A supplement of ECMS in a commercial FMD vaccine significantly enhanced FMDV-specific indirect hemagglutination assay titers as well as VP1-specific IgG and subclasses in pigs. Therefore, ECMS could be an alternative approach to improving swine FMD vaccination when the vaccine is poor to induce an effective immune response.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2007) studied Foot-and-mouth disease (FMD). Extract of the seeds of Momordica cochinchinensis (ECMS) vs. Vaccine without ECMS supplement was evaluated on FMDV- and VP1-specific immunoglobulin G (IgG) and subclasses and indirect hemagglutination assay titers. Supplementation of ECMS in a commercial FMD vaccine significantly enhanced FMDV-specific indirect hemagglutination assay titers and VP1-specific IgG and subclasses in pigs.
Synapse has enriched 10 related papers. Consider them for comparative context: